These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


933 related items for PubMed ID: 25820938

  • 1. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
    Lafuente-Lafuente C, Valembois L, Bergmann JF, Belmin J.
    Cochrane Database Syst Rev; 2015 Mar 28; (3):CD005049. PubMed ID: 25820938
    [Abstract] [Full Text] [Related]

  • 2. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
    Valembois L, Audureau E, Takeda A, Jarzebowski W, Belmin J, Lafuente-Lafuente C.
    Cochrane Database Syst Rev; 2019 Sep 04; 9(9):CD005049. PubMed ID: 31483500
    [Abstract] [Full Text] [Related]

  • 3. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
    Lafuente-Lafuente C, Longas-Tejero MA, Bergmann JF, Belmin J.
    Cochrane Database Syst Rev; 2012 May 16; (5):CD005049. PubMed ID: 22592700
    [Abstract] [Full Text] [Related]

  • 4. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
    Lafuente-Lafuente C, Mouly S, Longas-Tejero MA, Bergmann JF.
    Cochrane Database Syst Rev; 2007 Oct 17; (4):CD005049. PubMed ID: 17943835
    [Abstract] [Full Text] [Related]

  • 5. Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials.
    Lafuente-Lafuente C, Mouly S, Longás-Tejero MA, Mahé I, Bergmann JF.
    Arch Intern Med; 2006 Apr 10; 166(7):719-28. PubMed ID: 16606807
    [Abstract] [Full Text] [Related]

  • 6. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
    Naccarelli GV, Wolbrette DL, Khan M, Bhatta L, Hynes J, Samii S, Luck J.
    Am J Cardiol; 2003 Mar 20; 91(6A):15D-26D. PubMed ID: 12670638
    [Abstract] [Full Text] [Related]

  • 7. External electrical and pharmacological cardioversion for atrial fibrillation, atrial flutter or atrial tachycardias: a network meta-analysis.
    Kukendrarajah K, Ahmad M, Carrington M, Ioannou A, Taylor J, Razvi Y, Papageorgiou N, Mead GE, Nevis IF, D'Ascenzo F, Wilton SB, Lambiase PD, Morillo CA, Kwong JS, Providencia R.
    Cochrane Database Syst Rev; 2024 Jun 03; 6(6):CD013255. PubMed ID: 38828867
    [Abstract] [Full Text] [Related]

  • 8. Atrial fibrillation: rate control often better than rhythm control.
    Prescrire Int; 2004 Apr 03; 13(70):64-9. PubMed ID: 15148984
    [Abstract] [Full Text] [Related]

  • 9. Oral Class I and III antiarrhythmic drugs for maintaining sinus rhythm after catheter ablation of atrial fibrillation.
    Bray JJH, Warraich M, Whitfield MG, Peter CU, Baral R, Ahmad M, Ahmad S, Abraham GR, Kirresh A, Sahibzada MS, Muzaffar A, Tomson J, Lambiase PD, Captur G, Banerjee A, Providencia R.
    Cochrane Database Syst Rev; 2023 Mar 13; 3(3):CD013765. PubMed ID: 36915032
    [Abstract] [Full Text] [Related]

  • 10. Dronedarone for the treatment of atrial fibrillation and atrial flutter.
    Maund E, McKenna C, Sarowar M, Fox D, Stevenson M, Pepper C, Palmer S, Woolacott N.
    Health Technol Assess; 2010 Oct 13; 14(Suppl. 2):55-62. PubMed ID: 21047492
    [Abstract] [Full Text] [Related]

  • 11. [Antiarrhythmic treatment after reduction of atrial fibrillation by external shock].
    Koenig A, Theolade R, Chauvin M, Brechenmacher C.
    Presse Med; 1993 Nov 20; 22(36):1827-32. PubMed ID: 8309912
    [Abstract] [Full Text] [Related]

  • 12. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.
    Bollmann A, Husser D, Cannom DS.
    Am J Cardiovasc Drugs; 2005 Nov 20; 5(6):371-8. PubMed ID: 16259525
    [Abstract] [Full Text] [Related]

  • 13. Oral antiarrhythmic drugs in converting recent onset atrial fibrillation.
    Deneer VH, Borgh MB, Kingma JH, Lie-A-Huen L, Brouwers JR.
    Pharm World Sci; 2004 Apr 20; 26(2):66-78. PubMed ID: 15085940
    [Abstract] [Full Text] [Related]

  • 14. Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.
    Arsenault KA, Yusuf AM, Crystal E, Healey JS, Morillo CA, Nair GM, Whitlock RP.
    Cochrane Database Syst Rev; 2013 Jan 31; 2013(1):CD003611. PubMed ID: 23440790
    [Abstract] [Full Text] [Related]

  • 15. Electrical cardioversion for atrial fibrillation and flutter.
    Mead GE, Elder AT, Flapan AD, Kelman A.
    Cochrane Database Syst Rev; 2005 Jul 20; (3):CD002903. PubMed ID: 16034878
    [Abstract] [Full Text] [Related]

  • 16. Conversion of recent-onset atrial fibrillation with intravenous amiodarone: a meta-analysis of randomized controlled trials.
    Hilleman DE, Spinler SA.
    Pharmacotherapy; 2002 Jan 20; 22(1):66-74. PubMed ID: 11794432
    [Abstract] [Full Text] [Related]

  • 17. Arrhythmias in the intensive care patient.
    Trappe HJ, Brandts B, Weismueller P.
    Curr Opin Crit Care; 2003 Oct 20; 9(5):345-55. PubMed ID: 14508146
    [Abstract] [Full Text] [Related]

  • 18. Atrial fibrillation: choosing an antiarrhythmic drug.
    Rudo T, Kowey P.
    Curr Cardiol Rep; 2006 Sep 20; 8(5):370-6. PubMed ID: 16956453
    [Abstract] [Full Text] [Related]

  • 19. The RACE study in perspective of randomized studies on management of persistent atrial fibrillation.
    Hagens VE, Van Gelder IC, Crijns HJ, RAte Control Versus Electrical Cardioversion Of Persistent Atrial Fibrillation (RACE) Study Group.
    Card Electrophysiol Rev; 2003 Jun 20; 7(2):118-21. PubMed ID: 14618033
    [Abstract] [Full Text] [Related]

  • 20. [Treatment of atrial fibrillation in a Hungarian hospital department of cardiologic internal medicine at the turn of the millennium].
    Márk L, Erdej F, Dani G, Borbély M, Sziklai G, Nagy E, Hajdara I, Katona A.
    Orv Hetil; 2004 May 09; 145(19):1001-6. PubMed ID: 15181735
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 47.